Clinical Trial

Pentoxifylline and Lumbar Radiculopathy

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of this prospective controlled crossover study is to evaluate the efficacy and safety of pentoxifylline per os (800 mg daily) in the management of lumbar radiculopathy
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2017-02-18; most recent amendment 2025-05-18.
Status change: Recruiting → Active, Not Recruiting 2019-04-14
Trial Details
NCT Number NCT03060434
Lead Sponsor St Joseph University, Beirut, Lebanon
Conditions Lumbar Radiculopathy, Lumbar Disc Herniation, Lumbar Disc Disease
Enrollment 67 participants
Start Date 2018-06-01
Primary Completion 2022-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-21